Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial
Journal article published in 2005 by
Amadeu Pelegrí,
Lourdes Calvo 
,
Antonio Antón,
José I. Mayordomo,
Jesús Florián,
Santiago Vázquez,
Angels Arcusa,
Marta Martín-Richard,
José L. Bayo,
Eva Carrasco,
Javier Virizuela
,
Antonio Antón,
José I. Mayordomo,
Jesús Florián,
Santiago Vázquez,
Angels Arcusa,
Marta Martín-Richard,
José L. Bayo,
Eva Carrasco,
Javier Virizuela
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 